HOME >> MEDICINE >> NEWS
Drug-eluting stent controversy explored in the American Heart Hospital Journal

Shelton, Conn. - August 08, 2007 The Summer 2007 issue of The American Heart Hospital Journal explores one of the pivotal issues in cardiology today, the drug-eluting stent (DES). Through commentaries from ten leading national and international specialists, the issue presents a comprehensive discussion on the explosive growth and the potential risks of DESs.

The issue reports on the initial enthusiasm for drug-eluting stents, the great advances made possible by their use, and explores the significance of the benefits and disadvantages revealed through their high-volume adoption.

Dr. Ulrich Sigwart of University Hospital in Geneva, Switzerland, author of one of the studies, examines the sobering current appraisal of DES use, in contrast to the triumphs of their early success. Subacute stent thrombosis due to incomplete intimal coverage, the formation of blood clots that can occur when the inner layers of blood vessels are not fully treated, remains the Achilles heel of DES use, says Dr. Sigwart. The polymer matrix used for the delivery of drugs, which clearly induces inflammatory responses, may, in part, be responsible for very late thrombosis.

Dr. Renu Virmani and colleagues at the CVPath Institute of Gaithersburg, Maryland base the judgments in their article on the evidence obtained through pathologic studies of patients dying after stent implantation. These data indicate that DESs cause both substantial impairment in arterial healing characterized by lack of complete re-endothlialization (the re-healing of the inner surfaces of vessels after stenting) and persistence of fibrin, a protein that indicates blood clotting, when compared with bare metal stents. This delayed healing is the primary substrate underlying all cases of late DES thrombosis at autopsy.

In contrast, Drs. Williams and Abbott, of Brown Medical School and affiliated with Rhode Island Hospital, note, DESs are a revolutionary advancement in interventional
'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-Aug-2007


Page: 1 2

Related medicine news :

1. Drug-eluting and absorbable stents push interventional frontiers
2. Drug-eluting stents outperform radiation treatment for coronary restenosis in bare metal stents
3. Drug-eluting stents may cause allergic reactions
4. Drug-eluting stents successfully treat vein-graft disease
5. SCAI news: Drug-eluting stents prove mettle in heart attack patients
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. New study counts the economic cost of persistent pain in Australia
8. New biodegradable magnesium stents for coronary arteries
9. Emory University researchers find persistent and severe asthma associated with obesity
10. Persistent smokers may have higher risk to become depressed than never smokers
11. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... Calif. (PRWEB) , ... April 19, 2019 , ... According ... the United States alone comes with pesticide residue. Pesticides are sprayed on produce to ... and soils are what make up that thin, waxy layer that covers the skin ...
(Date:4/19/2019)... , ... April 18, 2019 , ... Residents in long-term-care ... by outside physicians. This is according to a study of U.S. men ... the auspices of the Brandman Research Institute (BRI) . The quality assurance study ...
(Date:4/18/2019)... ... 18, 2019 , ... Catalent, a global leader in clinical ... Clinical Supplies Group (GCSG) 2019 US Annual Conference at the Hyatt Regency Hill ... 2019. , Erin Vlack, Project Manager, will present a workshop titled “Bridging the ...
(Date:4/18/2019)... MONTPELIER, Vt. (PRWEB) , ... April 18, 2019 ... ... strengthening Vermont’s captive regulation in a variety of areas. This year’s bill proposed ... schedule and improvements to the statute governing group captive investments. The many enhancements ...
(Date:4/18/2019)... ... April 18, 2019 , ... WHAT:, ... for their care. Through the rise of online review sites and healthcare-related searches ... and transparency when making important purchasing decisions online. In order to elevate a ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... Global Lyme Alliance (GLA), the ... and awareness, and Ranger Ready Repellents, a new EPA-registered brand of body-worn ... prevention, including the proper use of repellents, to safeguard the public from tick ...
(Date:4/17/2019)... ... April 17, 2019 , ... As an employer do you feel overwhelmed by all of the ... to use? How can you best engage your employees? Do you have the budget for ... Join benefits administration experts Mike Ehrle, SVP of Strategic Partnerships, Hodges-Mace and Jay ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... Allegheny Health Network (AHN) and Gateway Health have launched a new program that ... life. , AHN’s Enhanced Pain Management Program brings together a range of ...
Breaking Medicine Technology:
Cached News: